Objective: The aim of this study was to investigate the influence of the antiproliferative agent 5-Fluorouracil (5FU) over inhibition of spinal bone formation in an experimental rat model.
In spinal surgery, with the exception of prosthetic implants, fusion is a desired outcome in all but two procedures. Generally, surgical interventions on immature spines (<10 years of age) are not performed with the intent of achieving fusion. Observation of spinal decompensation or short spinal height in fusions performed on young patients has indicated the need for non-fusion techniques. The main target of these techniques is to spare the spine from excessive deformation until the definitive fusion procedure or adequate maturation of the spine. However, unintended spontaneous fusions associated with the surgical exposure of the immature spine may arise as even a periosteal scratch can generate fusion in an immature spine. [1] [2] [3] [4] [5] [6] [7] Fusion is also an undesired outcome in decompression surgery for the treatment of degenerative spinal disease. In degenerative spinal dis-eases which necessitate fusion and decompression, postoperative restenosis may present a problem. Although not proven, the presence of a potential risk for restenosis is considered in cases in which osteogenetic agents such as bone morphogenetic protein (BMP) are used. [8] [9] [10] Since spinal fusion is generally desired, many studies in the literature have focused on the negative influence on fusion of various drugs and prevention of this effect. Therefore, only a limited numbers of studies have been designed to create fusion inhibition. In the literature, studies evaluating the inhibition of fusion by application of local agents have assessed the impacts of fibrin sealant and Adcon-L. [10, 11] Different opinions on the effects of fibrin sealant on fusion have been reported and studies have indicated a positive impact on fusion by holding the graft substitutes together. [12] Adcon-L is a biomaterial used for the inhibition of adhesion and fibrosis based on the theory that it prevents migration of proliferative cells to the lesion site. It has been shown to inhibit fusion based on the same principle. [11] In recent decades, the classical antiproliferative agent 5-Fluorouracil (5FU) has been increasingly used for prevention of fibrosis in ophthalmological procedures and hand surgery. We hypothesized that 5FU may be as effective as Adcon-L in the inhibition of spinal fusion.
The aim of the present study was to investigate the inhibitory effect on spinal fusion of local application of 5FU using a rat model.
Materials and methods
This study was conducted with approval of the Local Ethics Committee for Research on Animals of our institute.
Posterior spine exposure was performed on the thoracic region of two 2-week-old immature Sprague-Dawley rats in order to simulate a valid model for spontaneous spinal fusion. Subperiosteal denuding was applied to all muscles using a scalpel. Animals were sacrificed 4 weeks later. No osseous or fibrous proliferations were observed. For this reason, spinous process wiring was integrated to the procedure in an additional 2 immature rats in order to achieve a more proper spontaneous fusion model. However, optimum fixation was not achieved due to small posterior elements. Two 6-monthold Sprague-Dawley rats were subjected to aggressive subperiosteal denuding and spinous process wiring. Wires were removed at the postoperative 4th week. This process was recognized as the study model after observation of significant proliferative changes when compared to the un-operated segments.
This study included 30 6-month-old Sprague-Dawley rats, divided into 3 groups. Group 1 received Adcon-L (Adcon-L Adhesion Control Gel®; Gliatech Inc., Cleveland, OH, USA), Group 2 5FU (5-Fluorouracil®; Choongwae Pharma Corp., Seoul, South Korea) and Group 3 was the control group.
Following anesthesia with 10 mg/kg xylazine hydrochloride (Rompun®; Bayer AG, Leverkusen, Germany) and 40 mg/kg ketamine hydrochloride (Ketalar®; Eczacibasi, Istanbul, Turkey), the operation site was shaved and prepared for the surgery under sterile conditions. After the midline incision, posterior elements of the L4-L5 lumbar spine were reached and muscles were denuded. During the denuding process, cautery was not used. The entire muscle tissue and bone periosteum were denuded by scraping with a scalpel until observation of punctate bleeding over the lamina. Wires of 0.3-mm thickness were used on the spinous processes for the L4-L5 fixation. In Group 1, 50 µl Adcon-L was applied using its own apparatus on the exposed posterior elements of the L4-L5 vertebrae. In Group 2, 5FU was applied on the vertebrae by a sponge with single-touch technique [13] for 5 minutes following irrigation of the operation site with 10 ml saline. Group 3 (control group) received only 10 ml saline over the operation site.
Postoperative ambulatory activities and wound healing were monitored daily. None of the groups displayed neurological deficit, infection or difference in cutaneous healing. Rats were sacrificed by intravenous high-dose sodium pentothal (100 mg/kg) at postoperative 28 days and the entire lumbar vertebrae were excised en bloc through the former incision for histological examination.
Vertebrae were fixed in a 10% formaldehyde solution and decalcified with 10% formic acid and 8% HCl for 2 days. Sections of 5 µm thickness were prepared from the specimens and stained with hematoxylin-eosin (HE) and Masson' s trichrome (MT).
Cells were counted in 3 different fields of 3 sections for each subject. Similarly, inflammatory cells (polymorphonuclear cells, lymphocytes and monocytes) were counted under x400 magnification. He and Revel' s criteria were used to calculate the density of the fibroblasts in the scar tissue. [14] New bone formation and neovascularization were assessed microscopically according to the criteria of Emery et al. [15] (0-3: no new bone -maximum new bone, and 0-3: no neovascularization -maximum neovascularization) ( Table 1) . Preparations were histopathologically evaluated with regard to degree of scarring, inflammation, infection and Adcon-L resorption.
All data were analyzed using the Statistical Program for Social Science software v.10.0 (SPSS Inc., Chicago, IL, USA) with Kruskal-Wallis and Mann-Whitney U-tests. P values of less than 0.05 were considered significant.
Results
Ninety percent of new bone formation in the Adcon-L group was Grade 3 while 80% in the 5FU group was Grade 0 (Fig. 1) (Table 1 ). The majority of new bone formation in the control group was Grade 2 and 3. There was a statistically significant difference between the 5FU and control groups (p=0.0001).
Fibroblast density was low in the Adcon-L and 5FU groups. According to the criteria of He and Revel, [14] both the Adcon-L and 5FU groups demonstrated 70% density for Grade 2 fibroblasts and 70% density for Grade 3 fibroblasts in the control group (Table 1) . Fibroblast density was significantly reduced in the Adcon-L and 5FU groups compared to the control group (p=0.0001).
Inflammatory cell counts were elevated in the Adcon-L group and decreased in the 5FU group. Average inflammatory cell count under x400 magnification was 11.7 in the Adcon-L group while it was 1.8 for the 5FU group and 5.9 for the control group (Fig. 1) (Table 1 ). There was a significant difference between the 5FU and control groups in terms of inflammatory cell density (p=0.0001).
Assessment of the sections with regard to neovascularization based on Emery et al.' s [15] criteria revealed a prevalence of Grade 2 neovascularization in all the groups with no intergroup difference (p=0.1140). None of the agents had a negative or positive effect over neovascularization. Adcon-L was not completely resorbed in half of the subjects in the Adcon-L group.
Discussion
The issue of spontaneous, or unintended, fusion, in spinal surgery has been noted by many authors. [1] [2] [3] [4] [5] [6] [7] Osseous bridging and excessive fibrous reaction can affect the spine and hinder mobility in cases of spontaneous fusion. [16, 17] Spontaneous fusion and fibrosis that hinders correction of the deformity and leads to crankshaft deformity have been reported in cases of Luque instrumentation without fusion. [6, 18] Although the increased capacity for healing in immature spines is held responsible for spontaneous fusion, no significant change has been observed in the number of reports involving spontaneous fusion despite recent precautionary steps, such as small skin incision, minimal muscle denuding, effective hemostasis, wound site irrigation and use of the subfascial or subcutaneous method. Cahill et al. reported a spontaneous fusion rate of 89% in the spinal segments of 9 immature patients undergoing definitive fusion surgery. [7] Fibroblast count was performed in three different fields of three sections for each subject under x400 magnification and the average value of those counts was used.
‡ Polymorphonuclear cells, lymphocytes, and monocytes were counted in three different fields of three sections for each subject under x400 magnification and the average value of those counts was used. § Assessment of neovascularization was based on Emery et al.'s [15] criteria. Only a small number of studies have investigated the inhibitory effect of pharmaceutical agents in spinal surgery. Zou et al. [11] reported that Adcon-L inhibited spontaneous fusion to a certain degree. In this experimental study, following bilateral decortication of the transverse processes, the authors performed intertransverse fusion by applying an autograft acquired from the iliac wing on one side, while using a mixture comprised of the same amount of autograft and Adcon-L on the other side. Since we believe that this model and other fusion models in different experimental studies do not simulate spontaneous fusion properly, we created a model in which no method that can trigger fusion or fibrosis other than aggressive denuding and spinous process wiring was used. Fibrin glue, which generally acts as a carrier to hold the graft substitutes together, has also been used in the literature for similar purposes and is thought to prevent migration and distribution of graft materials and BMPs over areas where fusion is not desired. [9, 10] However, fibrin glue enables fusion control rather than inhibits fusion and bears importance particularly with regard to decompressive surgery.
The two agents used in our study have different mechanisms of action. The antiproliferative agent 5FU is a fluorinated pyrimidine analog used as a topical agent for the prevention of fibrosis after trabeculectomy and glaucoma filtration surgery. [19, 20] It has also been shown in experimental studies to reduce the fibrotic adhesions following tendon repairs. [21] [22] [23] The aim of the 5-minute long singletouch method is to avoid the side effects of 5FU while obtaining the benefit of its antiproliferative properties. This technique does not lead to cell death but alters the metabolism and behavior of cells by affecting cellular mRNAs of the cytoskeleton and inhibiting the normal chemical Inflammatory cell density pathways followed in DNA synthesis. [13, 23, 24] On the other hand, Adcon-L is comprised of polyglycan esters and a gelatin that can be absorbed within a phosphate-buffered solution. Its primary mechanism of action is as a mechanical barrier against the migrating fibroblasts. [25] Histological examination suggested that both agents affect the healing process over the operation site. Both agents were found to reduce the fibrotic tissue. However, there was a significant difference between 5FU and Adcon-L with regard to bone formation. Although we cannot explain the reason behind this significant difference, the delay concerning the absorption of Adcon-L appears to have a different influence over the healing process. In our study, Adcon-L failed to be absorbed in half of the samples in the Adcon-L group. Zou et al. [11] obtained a similar result. However, the significant elevation in the number of inflammatory cells in our study may be associated with the delayed absorption of Adcon-L and the antigenic properties of Adcon-L particles. Another factor that may explain this difference is the above described action mechanism of the two agents.
Our study had some limitations, including the absence of manual and radiological assessments and complications in evaluation of movement between the two vertebrae due to the small size of the evaluated area. [26] In the present study, no graft substitute was employed. Therefore, no detectable fusion mass was determined in the posterior spine which made the observation of osseous bridging, both radiologically and manually, impossible.
In conclusion, 5FU was significantly superior to Adcon-L in the inhibition of fibroblasts, inflammatory cells and bone formation. These findings suggest that 5FU can successfully inhibit fusion, fibrosis, and unwanted healing tissue in spinal surgery. Although 5FU appears to be a promising agent in this regard, further studies outlining the appropriate dosage and technique concerning its use on the human spine are necessary.
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